Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Intravenous Immunoglobulin Market Analysis & Trends 2017-2025 - Improving Health Care Infrastructure across the Globe - Research and Markets

Research and Markets
Posted on: 09 Nov 17

The "Global Intravenous Immunoglobulin Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

The Intravenous Immunoglobulin market is poised to grow strong during the forecast period 2017 to 2025

Some of the prominent trends that the market is witnessing include improving health care infrastructure across the globe, increasing number of chronic inflammatory demyelinating polyneuropathy (CIDP) patients and technological developments in the methods used for production and purification of IVIG products.

Based on therapeutic area the market is categorized into acute infections, immune deficiencies and autoimmune diseases. Furthermore Immune Deficiencies are divided into x-linked agammaglobulinemia, acquired compromised immunity conditions and hypogammaglobulinemia (primary immune deficiencies). Autoimmune Diseases are segmented into inflammatory diseases and immune thrombocytopenia (ITP).

Depending on product types the market is segregated by IGM, IGG, IGE, Immunoglobulin D (IGD) and IGA.

On the basis of plasma protein the market is bifurcated into albumin, factor IX, polyvalent IVIG, hyperimmunes (IM&IV) and factor VIII.

In terms of end user the market is segmented into home care, hospitals and clinics.

By application the market is classified into primary humoral immunodeficiency, immunodeficiency diseases, myasthenia gravis, hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), inflammatory myopathies, kawasaki disease, idiopathic thrombocytopenic purpura (ITP), guillain-barre syndrome (GBS), chronic lymphocytic leukemia, specific antibody deficiency (SAD), multifocal motor neuropathy, congenital AIDS and other applications.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Global Intravenous Immunoglobulin Market, By Therapeutic Area

5 Global Intravenous Immunoglobulin Market, By Product Type

6 Global Intravenous Immunoglobulin Market, By Plasma Protein

7 Global Intravenous Immunoglobulin Market, By End User

8 Global Intravenous Immunoglobulin Market, By Application

9 Global Intravenous Immunoglobulin Market, By Geography

10 Key Player Activities

11 Leading Companies

  • Biotest AG
  • Guizhou Taibang Biological Products Co.
  • Baxter International Inc
  • China Biologic Products, Inc
  • Shanghai RAAS Blood Products Co., Ltd
  • Grifols, S.A
  • Beijing Tiantan Biological Products Co., Ltd
  • Octapharma AG
  • CSL Limited
  • Hualan Biological Engineering Inc
  • Kedrion Biopharma
  • Biotest AG
  • OMRIX Biopharmaceuticals Ltd
  • LFB BIOTECHNOLOGIES
  • BDI Pharma Inc

For more information about this report visit https://www.researchandmarkets.com/research/7xvfmj/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20171109006599/en/

Business Wire
www.businesswire.com

Last updated on: 09/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.